Skip to search formSkip to main contentSkip to account menu

CpG Island Methylator Phenotype

Known as: CIMP, CIMP+ 
A phenotype whereby a subset of tumors are characterized by the simultaneous hypermethylation of multiple promoter-associated CpG islands.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Gliomas are a heterogeneous group of brain tumors with distinct biological and clinical properties. Despite advances in surgical… 
Highly Cited
2014
Highly Cited
2014
Approximately 70% of KRAS-positive colorectal cancers (CRCs) have a CpG island methylator phenotype (CIMP) characterized by… 
Highly Cited
2013
Highly Cited
2013
PURPOSE DNA methylation is a mechanism for gene expression silencing in cancer. Limited information is available for… 
Highly Cited
2009
Highly Cited
2009
Purpose: DNA methyltransferase-3B (DNMT3B) plays an important role in de novo CpG island methylation. Dnmt3b can induce colon… 
Highly Cited
2008
Highly Cited
2008
The CpG island methylator phenotype (CIMP) with widespread promoter CpG island methylation is a phenotype in colorectal cancer… 
Highly Cited
2007
Highly Cited
2007
It has been proposed that dietary factors such as folate, alcohol and methionine may be associated with colon cancer because of… 
Highly Cited
2007
Highly Cited
2007
Background Alterations in DNA methylation in cancer include global hypomethylation and gene-specific hypermethylation. It is not… 
Highly Cited
2006
Highly Cited
2006
Background: The concept of CpG island methylator phenotype (CIMP) is not universally accepted. Even if specific… 
Highly Cited
2005
Highly Cited
2005
PURPOSE The influence of molecular characteristics in prognosis of gastric cancer remains unclear. The aim of this study was to… 
Highly Cited
2002
Highly Cited
2002
Background and aims: A subgroup of colorectal cancers (CRC) referred to as the CpG island methylator phenotype (CIMP+) shows…